Seoul, South Korea

Jang Hoon Paek

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Yungjin Pharmaceutical Co., Ltd.. Active years: 1999-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jang Hoon Paek. Retrieved from https://idiyas.com/inventor/jang-hoon-paek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 12.5

ph-index = 2

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 1999-2000

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Jang Hoon Paek

Introduction

Jang Hoon Paek is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, holding a total of 2 patents. His work focuses on developing innovative compounds that have potential applications in various therapeutic areas.

Latest Patents

Among his latest patents are the Heterocycle-fused thiazole derivatives and the 4-amino-3-acylnaphthyridine derivatives. These inventions showcase his expertise in creating novel chemical structures that may lead to advancements in drug development.

Career Highlights

Throughout his career, Jang Hoon Paek has worked with reputable companies, including Yungjin Pharmaceutical Co., Ltd. and Man Sik Chang. His experience in these organizations has allowed him to refine his skills and contribute to important projects in the pharmaceutical industry.

Collaborations

Jang Hoon Paek has collaborated with several talented individuals, including Kwi Hyon Seo and Wahn Soo Choi. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Jang Hoon Paek's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to inspire advancements in drug development and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…